Teradyne Inc. Stock Climbs 3.1%, Outperforms Peers
Dow Jones2026/10/19 20:34This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Teradyne Inc. rose 3.1% to $335.17 on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index rising 0.4% to 7,690.73 and the Dow Jones Industrial Average falling 0.1% to 51,966.03.
The stock's rise snapped a five-day losing streak.
Teradyne Inc. closed 31.3% short of its 52-week high of $487.91, which the company achieved on June 30th.
The stock demonstrated a mixed performance when compared to some of its peers, as Keysight Technologies Inc. rose 1.4% to $335.86, Fortive Corp. fell 0.5% to $57.48, and Cohu Inc. rose 6.07% to $53.90.
Trading volume totaled 3.3 million, compared to the 50-day average of 2.5 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
October 19, 2026 16:34 ET (20:34 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Profit surges; amid concerns over U.S. surgical volume, JPMorgan maintains "Overweight" on Intuitive Surgical (ISRG.US) and raises target price to $475
Intuitive Surgical (ISRG.US), the global leader in surgical robots, released its Q3 2026 earnings report on October 20 (U.S. Eastern Time). On the same day, JPMorgan published a research report, maintaining an "Overweight" rating on the stock.
Allergy and autoimmune biotechnology company Lycia Therapeutics (LYCA.US) sets IPO price at $16-18 per share, plans to raise $250 million
Lycia Therapeutics announced the terms of its initial public offering (IPO) on Tuesday.
Dow Jones Top Markets Headlines at 3 AM ET: Asian Stocks Mixed as AI Spending Concerns Linger | U.S. ...
The Top 15 Stocks in the S&P 500 Are Now 47% of the Value. In 2000 Bubble, It Was 27%
Crypto prices
More
